Video

Streamline Your Path To Commercialisation With Alina® Variable-Dose Pen Injector Platform

Streamline your path to commercialization with Alina®, a variable-dose, disposable pen injector platform that brings confidence to patients and speed to partners.

Thanks to its broad therapeutic applications, Alina® can support GLP-1 therapies with off-the-shelf device variants for diabetes and obesity. Moreover, it allows for scalable market entry, ideal for biosimilars and generic launches.

Watch the video to discover more about Alina®, its patient-centric design, and intuitive handling steps.

access the Video!

Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Drug Delivery Leader? Subscribe today.

Subscribe to Drug Delivery Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Drug Delivery Leader

Please tell us more about you so that we can customize our newsletters to your specific interests:

What topics interest you? (Check all that apply.)

Stevanato Group